Iridex IRIX
NASDAQ IRIX
$0.74 -0.02 (-2.44%)
As of: Aug 21, 2026 · 1:15 PM EDT

Iridex (IRIX) Debt Ratio (2020 - 2021)

Iridex (IRIX) posted quarterly Debt Ratio of 0.05 for Q2 2021, down 43.56% quarter-over-quarter from 0.09 in Q1 2021.

Iridex (IRIX) Debt Ratio (2020 - 2021) Analysis & Trends

Iridex's Debt Ratio history runs 2 years deep, the most recent figure standing at 0.05 for Q2 2021.

  • In Q2 2021, Debt Ratio changed N/A year-over-year to 0.05; the TTM figure through Apr 2021 stood at 0.05 (changed N/A YoY), while the FY2021 annual figure was 0.09, changed N/A from the prior year.
  • Debt Ratio for Q2 2021 stood at 0.05, down from 0.09 in the prior quarter.
  • The five-year high for Debt Ratio was 0.09 in Q1 2021, with the low at 0.05 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 202.43 Bn 196.83 Bn 7.27 Bn 0.30
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn 0.31
3 Medtronic 119.10 Bn 109.88 Bn 6.41 Bn 0.30
4 Boston Scientific 74.72 Bn 74.18 Bn 3.85 Bn 0.28
5 Edwards Lifesciences 51.81 Bn 47.56 Bn 1.35 Bn 0.04
6 Dexcom 35.05 Bn 33.10 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.84 Bn 31.73 Bn 2.18 Bn 0.27
8 Koninklijke Philips 26.25 Bn 22.93 Bn 4.55 Bn 0.28
9 Steris 23.20 Bn 22.71 Bn 684.20 Mn 0.18
10 Iridex 12.94 Mn 8.26 Mn 4.30 Mn -

Historic Data

Download Data
DateValue
Apr 3, 2021 0.05
Jan 2, 2021 0.09
Sep 26, 2020 0.09